Physician profile
Sean T Gloth
NPI 1376538934
$200.62
in general payments reported to CMS, 2019-2025
9 companies · $58.94 in 2025
The $58.94 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.55 · 2020: $17.18 · 2021: $15.91 · 2022: $40.32 · 2024: $38.72 · 2025: $58.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $39.64 | 2024-2025 | Sucraid, Sucraid |
| Abbott Laboratories | $39.06 | 2025 | Aveir |
| Irhythm Technologies, INC. | $22.34 | 2022 | |
| Medtronic, INC. | $18.96 | 2024 | Cobalt Dr Mri Surescan |
| Philips North America LLC | $17.98 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.18 | 2020 | |
| Braemar Manufacturing, LLC | $16.79 | 2019 | |
| Pfizer INC. | $15.91 | 2021 | |
| Amgen INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Gloth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.